Literature DB >> 4258865

Kinetic studies on the inhibition of glycolytic kinases of human erythrocytes by 2,3-diphosphoglyceric acid.

J Ponce, S Roth, D R Harkness.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4258865     DOI: 10.1016/0005-2744(71)90120-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  6 in total

1.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement.

Authors:  P J Mulquiney; P W Kuchel
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: in vivo kinetic characterization of 2,3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR.

Authors:  P J Mulquiney; W A Bubb; P W Kuchel
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

3.  Partial purification and characterization of human erythrocyte phosphoglycollate phosphatase.

Authors:  R Zecher; H U Wolf
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

4.  Molecular forms of red blood cell hexokinase.

Authors:  G Fornaini; M Dachà; M Magnani; V Stocchi
Journal:  Mol Cell Biochem       Date:  1982-12-10       Impact factor: 3.396

5.  The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes.

Authors:  R Rosa; M O Prehu; Y Beuzard; J Rosa
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

6.  Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro.

Authors:  Inês Morais; Márcia M Medeiros; Maria Carvalho; Judit Morello; Sara M Teixeira; Suelma Maciel; Janice Nhantumbo; Ana Balau; Margarida T G Rosa; Fátima Nogueira; João Alexandre Rodrigues; Filomena A Carvalho; Alexandra M M Antunes; Ana Paula Arez
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.